Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy

被引:39
作者
Kostense, S
Raaphorst, FM
Notermans, DW
Joling, J
Hooibrink, B
Pakker, NG
Danner, SA
Teale, JM
Miedema, F
机构
[1] CLB Sanquin Blood Supply Fdn, Dept Clin Viroimmunol, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Clin & Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX USA
[4] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Natl AIDS Therapy Evaluat Ctr, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
关键词
CD4+ T cell; T-cell receptor-BV diversity; antiretroviral therapy;
D O I
10.1097/00002030-199818000-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Highly active antiretroviral therapy (HAART) induces a decline in viral load and a biphasic increase in peripheral blood CD4+ T-cell counts in HIV-infected patients. To evaluate the effect of HAART on T-cell receptor (TCR) diversity of repopulating naive and memory CD4+ T cells, complementarity determining region 3 (CDR3) spectratyping was performed. Design: For four patients treated with HAART, CD45RO+ (memory) and CD45RA+ (naive) CD4+ T cells were isolated from peripheral blood leukocyte samples obtained 1 week before, 1-2 months after, and 9-11 months after start of treatment. Methods: CDR3 regions were amplified by TCR-BV-specific nested PCR from CD4+ T-cell subsets. CDR3 size distributions and single-strand conformation polymorphism profiles were compared as an indication for TCR diversity. Results: Increasing blood CD4+ T-cell counts during the first 2 months of treatment coincided with increased perturbation of CDR3 patterns in CD4+ T-cell subsets, suggesting an early oligoclonal repopulation. At later timepoints, CDR3 size diversity increased when T-cell counts did not substantially decrease. Memory and naive CD4+ T cells generally showed comparable levels of perturbation. Conclusion: Diversity of the TCR repertoire reflected biphasic T-cell repopulation during HAART, compatible with initial redistribution and later CD4+ T-cell production. Sustained elevation of T-cell counts will in principle result in restoration of TCR diversity. (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:F235 / F240
页数:6
相关论文
共 15 条
[1]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[2]   CD4+ T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept [J].
Bell, EB ;
Sparshott, SM ;
Bunce, C .
IMMUNOLOGY TODAY, 1998, 19 (02) :60-64
[3]   HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J].
Connors, M ;
Kovacs, JA ;
Krevat, S ;
GeaBanacloche, JC ;
Sneller, MC ;
Flanigan, M ;
Metcalf, JA ;
Walker, RE ;
Falloon, J ;
Baseler, M ;
Stevens, R ;
Feuerstein, I ;
Masur, H ;
Lane, HC .
NATURE MEDICINE, 1997, 3 (05) :533-540
[4]   Limited CD4+ T-cell renewal in early HIV-1 infection:: Effect of highly active antiretroviral therapy [J].
Fleury, S ;
de Boer, RJ ;
Rizzardi, GP ;
Wolthers, KC ;
Otto, SA ;
Welbon, CC ;
Graziosi, C ;
Knabenhans, C ;
Soudeyns, H ;
Bart, PA ;
Gallant, S ;
Corpataux, JM ;
Gillet, M ;
Meylan, P ;
Schnyder, P ;
Meuwly, JY ;
Spreen, W ;
Glauser, MP ;
Miedema, F ;
Pantaleo, G .
NATURE MEDICINE, 1998, 4 (07) :794-801
[5]   Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire [J].
Gea-Banacloche, JC ;
Weiskopf, EE ;
Hallahan, C ;
de Quirós, JCLB ;
Flanigan, M ;
Mican, JM ;
Falloon, J ;
Baseler, M ;
Stevens, R ;
Lane, HC ;
Connors, M .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :579-585
[6]   Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy [J].
Gorochov, G ;
Neumann, AU ;
Kereveur, A ;
Parizot, C ;
Li, TS ;
Katlama, C ;
Karmochkine, M ;
Raguin, G ;
Autran, B ;
Debré, P .
NATURE MEDICINE, 1998, 4 (02) :215-221
[7]   Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir [J].
Kelleher, AD ;
Carr, A ;
Zaunders, J ;
Cooper, DA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :321-329
[8]  
Mackall CL, 1996, J IMMUNOL, V156, P4609
[9]   MOLECULAR ANALYSIS OF T-CELL REPERTOIRES - SPECTRATYPES GENERATED BY MULTIPLEX POLYMERASE CHAIN-REACTION AND EVALUATED BY RADIOACTIVITY OR FLUORESCENCE [J].
MASLANKA, K ;
PIATEK, T ;
GORSKI, J ;
YASSAI, M ;
GORSKI, J .
HUMAN IMMUNOLOGY, 1995, 44 (01) :28-34
[10]   Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine [J].
Notermans, DW ;
Jurriaans, S ;
de Wolf, F ;
Foudraine, NA ;
de Jong, JJ ;
Cavert, W ;
Schuwirth, CM ;
Kauffmann, RH ;
Meenhorst, PL ;
McDade, H ;
Goodwin, C ;
Leonard, JM ;
Goudsmit, J ;
Danner, SA .
AIDS, 1998, 12 (02) :167-173